ReviewFrontiers in cardiovascular medicine2019
Emerging Technologies for Percutaneous Mitral Valve Repair.
Review in Frontiers in cardiovascular medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 21 citations in OpenAlex.
- Advances in Transcatheter Mitral Valve Replacement (TMVR) in Patients with Mitral Annular Calcification: A Case Report of Acute Hemolytic Anemia and Review of Contemporary Approaches.Journal of clinical medicine · 2025Review
- Transcatheter mitral and tricuspid interventions-the bigger picture: valvular disease as part of heart failure.Frontiers in cardiovascular medicine · 2023Review
- Transapical mitral valve repair procedures: Primetime for microinvasive mitral valve surgery.Journal of cardiac surgery · 2022Review
- Patient-Specific Three-Dimensional Ultrasound Derived Computational Modeling of the Mitral Valve.Annals of biomedical engineering · 2022Article
- Innovative transcatheter procedures for the treatment of heart failure.Cardiovascular diagnosis and therapy · 2021Review
- Current Devices and Complications Related to Transcatheter Mitral Valve Replacement: The Bumpy Road to the Top.Frontiers in cardiovascular medicine · 2021Review
- Outcomes of open mitral valve replacement versus Transcatheter mitral valve repair; insight from the National Inpatient Sample Database.International journal of cardiology. Heart & vasculature · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 4 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mitral regurgitation (MR) is a common disease affecting more than 4 million people in the United States and the European Union. A significant number of percutaneous valves have been developed recently, specifically designed for the mitral anatomy, and with a promising evidence of good procedural and echocardiographic outcomes. However, even if transcatheter mitral valve replacement (TMVR) will have a role in the future of percutaneous treatment of both functional and degenerative mitral regurgitation, percutaneous mitral valve repair will always play a vital role in the treatment of MR because of the favorable safety profile and the fact that it respects the native anatomy. In this review, we will discuss the new emerging technologies under development to treat mitral regurgitation focusing on different devices that aim to target different components of the mitral anatomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.